Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Maas

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 1, 1995
Immunomagnetic purification of human breast carcinoma cells allows tumor-specific detection of multidrug resistance gene 1-mRNA by reverse transcriptase polymerase chain reaction in fine-needle aspiratesR A Maas, P F Bruning, A J Breedijk, et al.
The Veterinary Quarterly|November 22, 2000
Antigen quantification as in vitro alternative for potency testing of inactivated viral poultry vaccinesR A Maas, M P de Winter, S Venema, et al.
Vaccine|June 14, 2003
Correlation of haemagglutinin-neuraminidase and fusion protein content with protective antibody response after immunisation with inactivated Newcastle disease vaccinesR A Maas, M Komen, M van Diepen, et al.
In Vivo (Athens, Greece)|November 1, 1991
Tumour regression by IL-2 mediated stagnation of blood flowH J De Mik, J W Koten, R A Maas, et al.
Avian Pathology : Journal of the W.V.P.A|February 3, 2009
Efficacy of inactivated infectious bursal disease (IBD) vaccines: comparison of serology with protection of progeny chickens against IBD virus strains of varying virulenceR A Maas, S Venema, H L Oei, et al.
Immunobiology|November 1, 1992
Effector cells of low-dose IL-2 immunotherapy in tumor bearing mice: tumor cell killing by CD8+ cytotoxic T lymphocytes and macrophagesR A Maas, P A Roest, M J Becker, et al.
Immunobiology|July 1, 1993
Transfer of tumor immunity by both CD4+ and CD8+ tumor infiltrating T lymphocytes activated in vivo by IL-2 therapy of tumor bearing miceR A Maas, M J Becker, I S Weimar, et al.
International Immunology|October 1, 1991
Lymphokine-activated killer-cell-mediated killing of WiDr colon carcinoma cells is inhibited by K562 erythroleukemia cellsH F Dullens, J C Wind, R A Maas, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Histological analysis of IL-2 induced regression of murine solid SL2-tumorsR A Maas, H F Dullens, D Henk, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|April 29, 1998
A method to monitor mRNA levels in human breast tumor cells obtained by fine-needle aspirationM S de Lange, B Top, C Lambrechts, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 1, 1995
Immunomagnetic purification of human breast carcinoma cells allows tumor-specific detection of multidrug resistance gene 1-mRNA by reverse transcriptase polymerase chain reaction in fine-needle aspiratesR A Maas, P F Bruning, A J Breedijk, et al.
The Veterinary Quarterly|November 22, 2000
Antigen quantification as in vitro alternative for potency testing of inactivated viral poultry vaccinesR A Maas, M P de Winter, S Venema, et al.
Vaccine|June 14, 2003
Correlation of haemagglutinin-neuraminidase and fusion protein content with protective antibody response after immunisation with inactivated Newcastle disease vaccinesR A Maas, M Komen, M van Diepen, et al.
In Vivo (Athens, Greece)|November 1, 1991
Tumour regression by IL-2 mediated stagnation of blood flowH J De Mik, J W Koten, R A Maas, et al.
Avian Pathology : Journal of the W.V.P.A|February 3, 2009
Efficacy of inactivated infectious bursal disease (IBD) vaccines: comparison of serology with protection of progeny chickens against IBD virus strains of varying virulenceR A Maas, S Venema, H L Oei, et al.
Immunobiology|November 1, 1992
Effector cells of low-dose IL-2 immunotherapy in tumor bearing mice: tumor cell killing by CD8+ cytotoxic T lymphocytes and macrophagesR A Maas, P A Roest, M J Becker, et al.
Immunobiology|July 1, 1993
Transfer of tumor immunity by both CD4+ and CD8+ tumor infiltrating T lymphocytes activated in vivo by IL-2 therapy of tumor bearing miceR A Maas, M J Becker, I S Weimar, et al.
International Immunology|October 1, 1991
Lymphokine-activated killer-cell-mediated killing of WiDr colon carcinoma cells is inhibited by K562 erythroleukemia cellsH F Dullens, J C Wind, R A Maas, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Histological analysis of IL-2 induced regression of murine solid SL2-tumorsR A Maas, H F Dullens, D Henk, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|April 29, 1998
A method to monitor mRNA levels in human breast tumor cells obtained by fine-needle aspirationM S de Lange, B Top, C Lambrechts, et al.
Pageof 3